BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17969413)

  • 1. [Use of flow cytometry in diagnosis of urinary bladder cancer].
    Bozhenko VK; Kaprin AD; Kostin AA; Kulinich TM; Kudinova EA; Chazova NL; Mel'nikova NV; Nesterov PV
    Vopr Onkol; 2007; 53(4):468-72. PubMed ID: 17969413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ductal cytofluorometry of urine sediment level in the diagnosis of bladder cancer].
    Kaprin AD; Bozhenko VK; Kulinich TM; Nesterov PV; Kostin AA
    Vopr Onkol; 2006; 52(5):579-81. PubMed ID: 17168371
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ductal cytometry of urinary sediment in the diagnosis of bladder cancer].
    Bozhenko BK; Kaprin AD; Kulinich TM; Nesterov PV
    Vopr Onkol; 2009; 55(3):278-84. PubMed ID: 19670726
    [No Abstract]   [Full Text] [Related]  

  • 4. [Early diagnosis of bladder carcinoma].
    Mantur M; Jakubowska I; Kemona H
    Pol Merkur Lekarski; 2005 Feb; 18(104):173-5. PubMed ID: 17877124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage of urinary bladder cancer at first presentation.
    Al-Bazzaz PH
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):628-31. PubMed ID: 19587505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flow cytometry in urinary tract malignancies. III. Quantitative analysis of DNA histogram and application to bladder cancer detection, evaluation of the treatment and follow-up examination].
    Matsuura T; Tsujihashi H; Kanda H; Akiyama T; Kurita T
    Nihon Hinyokika Gakkai Zasshi; 1985 Jan; 76(1):89-95. PubMed ID: 4010114
    [No Abstract]   [Full Text] [Related]  

  • 7. Importance of urinary cytology and future role of flow cytometry.
    Dean PJ; Murphy WM
    Urology; 1985 Oct; 26(4 Suppl):11-5. PubMed ID: 4049625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optical coherence tomography in diagnosis of urinary bladder cancer].
    Danil'chenko DI; Al'-Shukri AS; Tkachuk VN
    Urologiia; 2009; (2):42-4. PubMed ID: 19526873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
    Paner GP; McKenney JK; Epstein JI; Amin MB
    Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Can MRI be used to distinguish between superficial and invasive transitional cell bladder cancer?].
    Tillou X; Grardel E; Fourmarier M; Bernasconi T; Demailly M; Hakami F; Saint F; Petit J
    Prog Urol; 2008 Jul; 18(7):440-4. PubMed ID: 18602604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could nuclear matrix protein 22 (NMP22) play a role with urine cytology in screening for bladder cancer?--experience at Kuwait University.
    Kapila K; Kehinde EO; Anim JT; Mojiminiyi OA; Vinsu A; George SS; Al-Maghrebi M; Al-Mulla F
    Cytopathology; 2008 Dec; 19(6):369-74. PubMed ID: 18631356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bladder cancer: diagnosis and prognosis--molecularbiological approach for prognostic factors. Discussion].
    Nihon Hinyokika Gakkai Zasshi; 1995 Jan; 86(1):55-65. PubMed ID: 7897922
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
    Hutterer GC; Karakiewicz PI; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Serretta V; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Perrotte P; Lotan Y; Marberger MJ; Shariat SF
    BJU Int; 2008 Mar; 101(5):561-5. PubMed ID: 18257856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder lymphoma.
    Johnson MH; Nepple KG; Humphrey PA
    J Urol; 2012 Jul; 188(1):269-70. PubMed ID: 22608747
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential of urinary biomarkers in early bladder cancer diagnosis.
    Lam T; Nabi G
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1105-15. PubMed ID: 18028019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary calreticulin in the diagnosis of bladder urothelial carcinoma.
    Kageyama S; Isono T; Matsuda S; Ushio Y; Satomura S; Terai A; Arai Y; Kawakita M; Okada Y; Yoshiki T
    Int J Urol; 2009 May; 16(5):481-6. PubMed ID: 19389084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleural metastasis in a patient with bladder cancer.
    Bonnin N; El Karak F; Droz JP; Flechon A
    J Clin Oncol; 2008 Jan; 26(2):329-30. PubMed ID: 18182674
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study on the diagnosis of urothelial cancer using multi-colour fluorescence in situ hybridization (FISH)--comparative analysis between FISH and cytology].
    Onishi T; Ichikawa T; Igarashi T
    Hinyokika Kiyo; 2008 Apr; 54(4):253-6. PubMed ID: 18516915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.